Prudential Financial
LYEL icon

Prudential Financial’s Lyell Immunopharma LYEL Stock Holding History

Prudential Financial’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,403
Closed -$25.9K – 2485
2025
Q1 		$25.9K Hold
2,403
– – ﹤0.01% 2239
2024
Q4 		$30.8K Sell
2,403
-4,845
-67% -$96K ﹤0.01% 2254
2024
Q3 		$200K Hold
7,248
– – ﹤0.01% 2516
2024
Q2 		$210K Buy
7,248
+2,450
+51% +$117K ﹤0.01% 2472
2024
Q1 		$214K Buy
4,798
+2,195
+84% +$94K ﹤0.01% 2453
2023
Q4 		$101K Hold
2,603
– – ﹤0.01% 2501
2023
Q3 		$76.5K Hold
2,603
– – ﹤0.01% 2466
2023
Q2 		$166K Buy
2,603
+1,980
+318% +$110K ﹤0.01% 2451
2023
Q1 		$29.4K Sell
623
-5
-0.8% -$267 ﹤0.01% 2545
2022
Q4 		$43.6K Buy
628
+4
+0.6% +$397 ﹤0.01% 2504
2022
Q3 		$92K Buy
624
+6
+1% +$812 ﹤0.01% 2518
2022
Q2 		$81K Buy
618
+70
+13% +$7.15K ﹤0.01% 2543
2022
Q1 		$55K Buy
+548
New +$66.4K ﹤0.01% 2569

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Prudential Financial's LYEL Position: Q2 2025 in Review

Prudential Financial sold out of Lyell Immunopharma (LYEL) in Q2 2025, closing a stake of 2,403 shares — an estimated $25.9K sold.

Prudential Financial first reported a position in LYEL in Q1 2022 and held it in 13 quarters. The position peaked at $214K in Q1 2024. 69 funds tracked by Wall St. Rank hold LYEL as of Q2 2025.

  • Prudential Financial reported no remaining Lyell Immunopharma position as of Q2 2025 after selling out during the quarter.
  • Prudential Financial sold 2,403 Lyell Immunopharma shares in Q2 2025, an estimated $25.9K.
  • Prudential Financial first reported a position in Lyell Immunopharma in Q1 2022 and held it in 13 quarters.
  • Prudential Financial's Lyell Immunopharma position peaked at $214K in Q1 2024.
  • 69 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2025.

Based on Prudential Financial's 13F filing for Q2 2025, filed 12 Aug 2025.